Beyond the Scale: GLP-1 Medications' Impact on Body and Mind
GLP-1 medications are transforming lives by addressing not just the scale, but overall well-being, including mental clarity and energy levels. Originally approved in 2005 for type 2 diabetes treatment, these drugs—such as Ozempic, Wegovy, Zepbound, and tirzepatide—have gained popularity for weight management, with surveys showing roughly one in eight Americans having tried them. As demand surges, including the recent release of a pill version of Wegovy (semaglutide), patients like Alexis Ioane are discovering benefits that extend beyond physical changes.
What Are GLP-1 Medications and How Do They Work?
GLP-1 receptor agonists mimic a natural hormone that regulates appetite and blood sugar. As explained by Dr. Steve Warren, medical director at Regenerative Wellness Center, "So basically, it's just that signal to say to your body, 'Hey, I'm full, I don't need any food.'" This mechanism helps control hunger, stabilizes glucose levels, and supports significant weight loss—typically 15 to 25 percent of body weight for the average person.
These weekly injections (or now, oral options like the new Wegovy pill) were first developed for metabolic conditions but have expanded to broader health concerns. For patients with high blood pressure, insulin resistance, or borderline diabetes, GLP-1s offer a targeted approach when combined with lifestyle changes.
From Diabetes to Weight Management: A Brief History
Since their 2005 approval, more versions have entered the market, making GLP-1 medications more accessible. Drugs like semaglutide (in Ozempic and Wegovy) and tirzepatide (in Zepbound) lead the way, often costing $150 to more than $1,000 per month depending on dosage, formulation, and insurance coverage.
Physical Benefits: Weight Loss, Energy, and Metabolic Health
Patients report profound physical shifts. Alexis Ioane, a mother of two struggling with high blood pressure, started tirzepatide two months ago despite her aversion to needles. After initial extreme fatigue, she noticed a drop on the scale and improved overall vitality. "I have a lot more energy for my kids. I have a lot more motivation," she shared.
Erykah Tuakimoana's journey is even more dramatic. Post her third baby, bloodwork revealed off insulin levels and borderline diabetes. Over three years on a GLP-1 medication, paired with better eating habits and strength training, she lost more than 100 pounds. "My body just was not changing and responding to literally anything," she said, emphasizing, "This isn't a quick fix; you have to change your lifestyle as well."
These stories highlight how GLP-1s quiet "food noise"—constant thoughts about eating. Tuakimoana noted, "I grew up constantly thinking about food... It really just keeps that food noise at bay." This suppression extends to metabolic improvements, reducing risks like type 2 diabetes progression.
Mental Health Impacts: A Double-Edged Sword
While physical gains are clear, GLP-1 medications' effects on the mind spark debate. Dr. Kristin Francis, a psychiatrist with Huntsman Mental Health Institute, is conflicted: "On one hand, we're being asked to have this idealized body type in our society, and on the other hand, we're being shamed if someone gets to it."
Some studies show mood improvements, but others suggest risks of anxiety or depression, especially for those with pre-existing conditions. Initial trials excluded participants with major depressive disorder or significant psychiatric history, leaving data gaps. "We just don't have enough information yet," Francis said. "We would say you need to proceed with caution and keep a good eye on your depressive and anxious symptoms."


